Search Results - person:"Medina-Lara, Antonieta"

Validation of the Underlying Assumptions of the Quality-Adjusted Life-Years Outcome: Results from the ECHOUTCOME European Project

Beresniak, Ariel; Medina-Lara, Antonieta; Auray, Jean; … - In: PharmacoEconomics 33 (2015) 1, pp. 61-69

This European study contributes to establishing that the QALY multiplicative model is an invalid measure. This explains why costs/QALY estimates may vary greatly, leading to inconsistent recommendations relevant to providing access to innovative medicines and health technologies. HTA agencies...

Persistent link: https://www.econbiz.de/10011152267

Unit Costs for Delivery of Antiretroviral Treatment and Prevention of Mother-to-Child Transmission of HIV: A Systematic Review for Low- and Middle-Income Countries

Galárraga, Omar Galrraga; Wirtz, Veronika J.; … - In: PharmacoEconomics 29 (2011) 7, pp. 579-599

As antiretroviral treatment (ART) for HIV/AIDS is scaled up globally, information on per-person costs is critical to improve efficiency in service delivery and to maximize coverage and health impact. The objective of this study was to review studies on unit costs for delivery of adult and...

Persistent link: https://www.econbiz.de/10011005080

Unit Costs for Delivery of Antiretroviral Treatment and Prevention of Mother-to-Child Transmission of HIV

Galárraga, Omar; Wirtz, Veronika; Figueroa-Lara, Alejandro - In: PharmacoEconomics 29 (2011) 7, pp. 579-599

Persistent link: https://www.econbiz.de/10011001733